Health Care: Drugs

Allergan Inc (AGN: NYSE)

$232.4 -0.08 | -0.03%
02/26/15 - 04:00 PM ET
Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 7.24B 6.30B 5.81B 5.42B
Cost of Sales 718.90M 669.70M 656.00M 614.50M
Gross Operating Profit 6.52B 5.63B 5.15B 4.80B
Selling, General, and Administrative Expenses 2.84B 2.52B 2.27B 2.25B
Research & Development 1.19B 1.04B 989.60M 902.80M
Operating Income before D & A (EBITDA) 2.49B 2.07B 1.89B 1.66B
Depreciation & Amortization 235.90M 242.80M 250.80M 261.80M
Interest Income 7.70M 6.80M 6.70M 6.90M
Other Income - Net 41.70M -10.30M -23.10M -500.00K
Special Income / Charges 0.00 -11.40M -22.30M -23.70M
Total Income Before Interest Expenses (EBIT) 2.06B 1.81B 1.60B 1.37B
Interest Expense 69.40M 75.00M 63.60M 71.80M
Pre-Tax Income 1.99B 1.73B 1.53B 1.30B
Income Taxes 456.70M 458.30M 430.80M 361.60M
Minority Interest 4.60M 3.60M 3.70M 3.60M
Net Income From Continuing Operations 1.53B 1.27B 1.10B 938.10M
Net Income From Discontinued Operations -3.80M -283.80M 0.00 0.00
Net Income From Total Operations 1.53B 988.70M 1.10B 938.10M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 1.52B 985.10M 1.10B 934.50M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
1.78B 1.29B 1.13B 966.40M
Preferred Dividends
Net Income Available To Common 1.53B 1.27B 1.10B 938.10M
Basic EPS from Continuing Ops. 5.13 4.28 3.64 3.07
Basic EPS from Discontinued Ops. -0.01 -0.96 0.00 0.00
Basic EPS from Total Operations 5.12 3.32 3.64 3.07
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 5.12 3.32 3.64 3.07
Basic Normalized Net Income/Share 5.95 4.34 3.74 3.16
EPS fr Continuing Ops. 5.03 4.20 3.58 3.01
EPS fr Discontinued Ops -0.02 -0.96 0.00 0.00
EPS fr Total Ops. 5.01 3.24 3.58 3.01
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.02 0.00 0.00
EPS, Total 5.01 3.26 3.58 3.01
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
5.83 4.26 3.67 3.10
Dividends Paid per Share 0.20 0.20 0.20 0.20

Portfolios with AGN

Latest AGN Headlines from TheStreet

More Financial News for AGN

Press Releases for AGN

See All Press Releases

Partner Headlines for AGN

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter